Ruxolitinib phosphate

Pricing Availability   Qty
Description: Phosphate salt of Ruxolitinib (Cat. No. 7064); potent and selective JAK1/JAK2 inhibitor
Chemical Name: (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphate
Purity: ≥98% (HPLC)
Pathways (1)

Biological Activity for Ruxolitinib phosphate

Ruxolitinib phosphate is a phosphate salt of Ruxolitinib (Cat. No. 7064). Potent and selective JAK1/JAK2 inhibitor; orally bioavailable.

Compound Libraries for Ruxolitinib phosphate

Ruxolitinib phosphate is also offered as part of the Tocriscreen Kinase Inhibitor Library and Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.

Technical Data for Ruxolitinib phosphate

M. Wt 404.37
Formula C17H18N6.H3O4P
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1092939-17-7
PubChem ID 25127112
Smiles OP(O)(O)=O.N#CC[C@@H](N1C=C(C2=C3C=CNC3=NC=N2)C=N1)C4CCCC4

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Ruxolitinib phosphate

Solvent Max Conc. mg/mL Max Conc. mM
DMSO 40.44 100
ethanol 4.04 10

Preparing Stock Solutions for Ruxolitinib phosphate

The following data is based on the product molecular weight 404.37. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.47 mL 12.36 mL 24.73 mL
5 mM 0.49 mL 2.47 mL 4.95 mL
10 mM 0.25 mL 1.24 mL 2.47 mL
50 mM 0.05 mL 0.25 mL 0.49 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets for Ruxolitinib phosphate

References for Ruxolitinib phosphate

References are publications that support the biological activity of the product.

Lin et al (2019) Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction. Org.Lett. 11 1999 PMID: 19385672

Quintás-Cardama et al (2010) Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood 113 3109 PMID: 20130243

If you know of a relevant reference for Ruxolitinib phosphate, please let us know.

View Related Products by Target

View Related Products by Product Action

View all JAK Inhibitors

Keywords: Ruxolitinib phosphate, Ruxolitinib phosphate supplier, Potent, selective, JAK1/JAK2, inhibitors, inhibits, JAK1, JAK2, orally, bioavailable, active, in, vivo, JAK, Kinase, 7048, Tocris Bioscience

Citations for Ruxolitinib phosphate

Citations are publications that use Tocris products.

Currently there are no citations for Ruxolitinib phosphate. Do you know of a great paper that uses Ruxolitinib phosphate from Tocris? Please let us know.

Reviews for Ruxolitinib phosphate

There are currently no reviews for this product. Be the first to review Ruxolitinib phosphate and earn rewards!

Have you used Ruxolitinib phosphate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Pathways for Ruxolitinib phosphate

JAK-STAT Signaling Pathway

JAK-STAT Signaling Pathway

The JAK-STAT signaling pathway has several roles, including the control of cell proliferation and hematopoiesis. It is the main signal transduction cascade from cytokine receptors.